BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7075190)

  • 1. Evaluation of sulprostone for second trimester abortions and its effects on liver and kidney function.
    Ranjan V; Hingorani V; Kinra G; Agarwal N; Pande Y
    Contraception; 1982 Feb; 25(2):175-84. PubMed ID: 7075190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First and midtrimester abortion with intramuscular injections of sulprostone.
    Ballard CA
    Contraception; 1981 Aug; 24(2):145-50. PubMed ID: 7297066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with 16-phenoxy-omega-tetranor-PGE2-methylsulfonamide (sulprostone) for termination of second trimester pregnancy.
    Fylling P
    Contraception; 1982 Sep; 26(3):279-83. PubMed ID: 7172674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
    Nilsson S; Zador G; Nygren KG; Wide L
    Gynecol Obstet Invest; 1981; 12(4):203-10. PubMed ID: 7250783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulprostone, a synthetic PGE2 analogue in first trimester abortion. Clinical efficacy and influence on serum progesterone of different single doses.
    Larsson B; Jonasson A; Carlström K
    Gynecol Obstet Invest; 1990; 29(1):10-2. PubMed ID: 2351329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of two stable prostaglandin E analogues for termination of early pregnancy and for cervical dilatation.
    Bygdeman M; Bremme K; Christensen N; Lundström V; Gréen K
    Contraception; 1980 Nov; 22(5):471-83. PubMed ID: 7471738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Termination of normal and pathological pregnancy with Sulprostone.
    Fischer Z; Chwalisz K; Michałkiewicz W
    Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Termination of second trimester pregnancy by intramuscular injection of 16-phenoxy-omega-17,18,19,20-tetranor-PGE2 methyl sulphonylamide.
    Int J Gynaecol Obstet; 1982 Oct; 20(5):383-6. PubMed ID: 6128270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological action and half life in plasma or intramuscular sulprostone for termination of second trimester pregnancy.
    Briel RC; Lippert TH
    Prostaglandins Med; 1981 Jan; 6(1):1-8. PubMed ID: 7220653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of different prostaglandin analogues for terminating pregnancy at different terms.
    Manuilova IA
    Acta Med Hung; 1986; 43(2):133-8. PubMed ID: 3588156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Termination of second trimester pregnancy with sulprostone and mifepristone: a randomized double-blind placebo-controlled trial.
    Ho PC; Ma HK
    Contraception; 1993 Feb; 47(2):123-9. PubMed ID: 8449013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of various intracervically administered PG gel preparations for termination of first trimester pregnancies.
    Rath W; Meyer D; Hildebrandt J; Hilgers R; Kuhn W
    Contraception; 1983 Sep; 28(3):209-22. PubMed ID: 6357631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulprostone for preoperative cervical dilatation in primigravidae scheduled for late first trimester termination of pregnancy.
    Jerve F; Fylling P
    Arch Gynecol; 1983; 233(3):199-203. PubMed ID: 6625666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose sulprostone for pregnancy termination in cases of fetal abnormality.
    Kanhai HH; Keirse MJ
    Prenat Diagn; 1993 Feb; 13(2):117-21. PubMed ID: 8464832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new therapeutic approach for terminating intact and disturbed pregnancies: three years of experience with the prostaglandin E2-derivative sulprostone (SHB 286) (author's transl)].
    Schmidt-Gollwitzer K; Schüssler B; Elger W; Schmidt-Gollwitzer M
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):667-75. PubMed ID: 478268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of sulprostone for cervical dilation in nulliparas during 1st trimester abortions].
    Giannone R; Poli M; Bernardi F; Ferrari E
    Minerva Ginecol; 1988 Sep; 40(9):553-5. PubMed ID: 3222011
    [No Abstract]   [Full Text] [Related]  

  • 17. Improvement in artificial second-trimester abortion with a new tissue-selective prostaglandin E2 derivative.
    Schmidt-Gollwitzer R; Schuessler B; Elger W; Schmidt-Gollwitzer M
    Am J Obstet Gynecol; 1980 Aug; 137(7):867-8. PubMed ID: 7405982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of intramuscular sulprostone and vacuum aspiration for termination of early pregnancy.
    Prasad S; Kinra G; Hingorani V
    Contraception; 1985 Nov; 32(5):429-35. PubMed ID: 4085246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open study comparing two regimens of gemeprost for the termination of pregnancy in the second trimester.
    Thong KJ; Baird DT
    Acta Obstet Gynecol Scand; 1992 Apr; 71(3):191-6. PubMed ID: 1317641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulprostone (Nalador) versus gemeprost (Cervagem) for cervical priming in the termination of pregnancy during the first trimester.
    Heinzl S; Hendry M
    Contraception; 1987 Mar; 35(3):271-82. PubMed ID: 3608482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.